Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
Effects of Gastrostomy on Quality of Life and Survival in Patients With Amyotrophic Lateral Sclerosis
Sponsor: Central Hospital, Nancy, France
A observational or N/A phase clinical study on Amyotrophic Lateral Sclerosis, this trial is completed. The trial is conducted by Central Hospital, Nancy, France and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central Hospital, Nancy, France
- Centre Hospitalier Universitaire de Nice
- Neurological department of Lyon University Hospital
- University Hospital, Angers
- University Hospital, Bordeaux
- University Hospital, Caen
- University Hospital, Clermont-Ferrand
- University Hospital, Grenoble
- University Hospital, Lille
- University Hospital, Limoges
- University Hospital, Marseille
- University Hospital, Montpellier
- University Hospital, Paris
- University Hospital, Strasbourg
- University Hospital, Toulouse
- University Hospital, Tours
For direct contact, visit the study record on ClinicalTrials.gov .